Platinum(IV) antitumour compounds: their bioinorganic chemistry
Top Cited Papers
- 1 October 2002
- journal article
- Published by Elsevier BV in Coordination Chemistry Reviews
- Vol. 232 (1-2), 49-67
- https://doi.org/10.1016/s0010-8545(02)00026-7
Abstract
No abstract availableKeywords
This publication has 114 references indexed in Scilit:
- Reduction of the anti-cancer drug analogue cis,trans,cis-[PtCl2(OCOCH3)2(NH3)2] by L-cysteine and L-methionine and its crystal structure †J. Chem. Soc., Dalton Trans., 1999
- Cellular and molecular determinants of cisplatin resistanceEuropean Journal Of Cancer, 1998
- A long-lived ascorbate radical in the platinum(II) catalysed reductions of platinum(IV) antitumor drugsJ. Chem. Soc., Dalton Trans., 1997
- Reduction of trans-dichloro- and trans-dibromo-tetracyanoplatinate(IV) by L-methionineJ. Chem. Soc., Dalton Trans., 1997
- Determination of metabolites of a novel platinum anticancer drug JM216 in human plasma ultrafiltratesJournal of Pharmaceutical and Biomedical Analysis, 1995
- The molecular basis of cisplatin sensitivity/resistanceEuropean Journal Of Cancer, 1994
- Detection of DNA strand breaks in Escherichia coli treated with platinum(IV) antitumor compoundsChemico-Biological Interactions, 1990
- Cross-linking of glutathione to DNA by cancer chemotherapeutic platinum coordination complexesChemico-Biological Interactions, 1987
- Complexes of Cysteine and Cysteinemethylester with Pd(II) and Pt(II)Journal of Inorganic and Nuclear Chemistry, 1979
- Structure and activity relationships of platinum complexes with anti-tumour activityChemico-Biological Interactions, 1975